Acne valgaris patients
Conditions
Interventions
After washing the test product twice a day, in the morning and before bedtime, apply the appropriate amount to the affected area (pigmentation site) every day for 12 weeks.
Sponsors
Meiwa Hospital, Medical Corporation
Eligibility
Sex/Gender
All
Inclusion criteria
Inclusion criteria: Patients with pigmentation symptoms of acne vulgaris
Exclusion criteria
Exclusion criteria: 1)Patients with experience of skin symptoms such as contact dermatitis by the components and similar components of this research. 2)A patient with an inappropriate rash or other lesion in the affected area. 3)Patients with unstable symptoms of disease and complications that cause pigmentation. 4)Patients undergoing treatment for pigmentation or patients who have not been over one year since the end of treatment. 5)Pregnant, possibely pregnant, hope to be pregnant, or breastfeeding woman.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Improvement of post-inflammatory pigmentation(PIH):4 weeks after treatment starts, 8weeks, 12 weeks evaluation of improvement by 'investigator's global improvement rating' in each observation period | — |
Countries
Japan
Contacts
Public ContactOgaki Yoshitaka
EBC&M LLC. Business Promotion Department
Outcome results
None listed